Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC The Agilent 1260 Infinity Bio-Inert Quaternary LC System and the AdvanceBio SEC 300Å, 2.7 µm Column Application Note Biologics and Biosimilars Author Abstract M.Sundaram Palaniswamy Monoclonal antibody aggregation can arise…
Klíčová slova
innovator, aggregates, biosimilar, rituximab, intact, fragments, mau, sec, stressed, mabs, advancebio, monomer, stress, area, aggregation